Greetings! I’m Elif — a pharmacist and scientist focused on developing innovative immunotherapeutic strategies and improving patient outcomes.
My research interests center on translational immunology, and I am particularly interested in developing effective strategies for solid tumors by evaluating therapeutic efficacy in clinical settings, predicting patient responses, and minimizing treatment-related toxicities.
My research interests center on translational immunology, and I am particularly interested in developing effective strategies for solid tumors by evaluating therapeutic efficacy in clinical settings, predicting patient responses, and minimizing treatment-related toxicities.
I am motivated to approach scientific challenges holistically, integrating perspectives such as biotechnology, immunology, machine learning, and cell engineering. Alongside discovery and development, I am keen to address the manufacturing and cost-related challenges of immunotherapies, with the goal of making these treatments more accessible, scalable, and impactful worldwide.
By combining my clinical background with research, I aim to contribute to meaningful advances that improve cancer survival rates.
By combining my clinical background with research, I aim to contribute to meaningful advances that improve cancer survival rates.